Francis Remedies (India) Profile
Key Indicators
- Authorised Capital ₹ 1.60 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.51 Cr
as on 16-11-2024
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 12.23 Cr
as on 16-11-2024
- Revenue 198.00%
(FY 2023)
- Profit 96.72%
(FY 2023)
- Ebitda -256.31%
(FY 2023)
- Net Worth -1.70%
(FY 2023)
- Total Assets 43.54%
(FY 2023)
About Francis Remedies (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.60 Cr and a paid-up capital of Rs 1.51 Cr.
The company has closed loans amounting to ₹12.23 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Tilak Raj and Vikas Tyagi serve as directors at the Company.
- CIN/LLPIN
U24231DL2006PTC146931
- Company No.
146931
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Feb 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Francis Remedies (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tilak Raj  | Director | 26-Jun-2021 | Current |
| Vikas Tyagi | Director | 29-Mar-2023 | Current |
Financial Performance and Corporate Structure Insights of Francis Remedies (India).
Francis Remedies (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 198% increase. The company also saw a substantial improvement in profitability, with a 96.72% increase in profit. The company's net worth dipped by a decrease of 1.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Francis Remedies (India)?
Unlock access to Francis Remedies (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 06 Aug 2010 | ₹5.00 M | Satisfied |
Canara Bank Creation Date: 28 Mar 2009 | ₹1.00 Cr | Satisfied |
Canara Bank Creation Date: 28 Mar 2008 | ₹5.65 Cr | Satisfied |
How Many Employees Work at Francis Remedies (India)?
Francis Remedies (India) has a workforce of 10 employees as of Sep 16, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Francis Remedies (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Francis Remedies (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
